Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Asthma
Interventions
DRUG

Ciclesonide

Trial Locations (19)

602-715

Altana Pharma/Nycomed, Busan

700-712

Altana Pharma/Nycomed, Daegu

700-721

Altana Pharma/Nycomed, Daegu

301-721

Altana Pharma/Nycomed, Daejeon

220-701

Altana Pharma/Nycomed, Gangwon-do

501-757

Altana Pharma/Nycomed, Gwangju

420-767

Altana Pharma/Nycomed, Gyeonggi-do

442-721

Altana Pharma/Nycomed, Gyeonggi-do

561-712

Altana Pharma/Nycomed, Jeonju

361-711

Altana Pharma/Nycomed, Jungbuk

330-715

Altana Pharma/Nycomed, Jungnam

120-749

Altana Pharma/Nycomed, Seoul

133-792

Altana Pharma/Nycomed, Seoul

134-701

Altana Pharma/Nycomed, Seoul

135-710

Altana Pharma/Nycomed, Seoul

137-701

Altana Pharma/Nycomed, Seoul

138-736

Altana Pharma/Nycomed, Seoul

140-757

Altana Pharma/Nycomed, Seoul

158-710

Altana Pharma/Nycomed, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY